Quaker BioVentures
Venture capital · Philadelphia, Pennsylvania, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio3 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Prelude Therapeutics
28Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Imvax | Biotech | Active | Jul 30, 2020 | $151.8M |
| Whisper Biosciences | Biotech | Active | — | — |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
Peer ranks
Portfolio size#108
Portfolio exits#160
Raises, 12 months#88
Co-investors#64
Co-investors
- BioAdvanceVenture capital3 shared
- Boxer CapitalVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- Frazier Healthcare PartnersVenture capital2 shared
- KBL Healthcare VenturesVenture capital2 shared
- Penn MedicineVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- Perceptive Life SciencesVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- TPG BiotechVenture capital2 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.